A Phase 3 Study of Pembrolizumab in Combination With Carboplatin/Taxane (Paclitaxel or Nab-paclitaxel) Followed by Pembrolizumab With or Without Maintenance MK-2870 in the First-line Treatment of Metastatic Squamous Non-small Cell Lung Cancer
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) This is a phase 3…
Study of the Bria-IMT Regimen and CPI vs Physicians’ Choice in Advanced Metastatic Breast Cancer (BRIA-ABC)
Randomized, Open-Label Study Of The Bria-IMT Regime And Check Point Inhibitor VS Physician’s Choice In Advanced Metastatic Breast Cancer This…
A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer
The main objectives of this study are to determine the feasibility and safety of AU-011 treatment of bladder cancer utilizing…
A Beta-only IL-2 ImmunoTherapY Study (ABILITY-1)
A Phase 1/2 Open Label, Dose Escalation and Expansion Study of MDNA11, IL-2 Superkine, Administered Alone or in Combination with…
Perioperative Pain Management Strategies in Oncoplastic Breast Surgery
Breast Cancer Undergoing Surgical Treatment,/h3> All breast cancer patients who present in the Margie Petersen Breast Center for initial surgical…
Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer (Solar-Recur)
A Phase 3, Multicenter, Open Label Study to Test the Diagnostic performance of Copper Cu 64 PSMA I&T PET/CT in…
A Randomized Controlled Phase 2 Study of the Ketogenic Diet Versus Standard Dietary Guidance for Patients With Newly Diagnosed Glioblastoma in Combination With Standard-of-care Treatment
This is a Phase 2, randomized two-armed, multi-site study of 170 patients with newly diagnosed glioblastoma multiforme. Patients will be…
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study This study will evaluate the efficacy and safety of inavolisib in combination…
Study of Chemotherapy Plus Ipatasertib for People With Solid Tumors With AKT Mutations, A ComboMATCH Treatment Trial
This phase II ComboMATCH treatment trial tests the usual treatment of chemotherapy (paclitaxel) plus ipatasertib in patients with solid tumor…
Testing the Use of Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone Receptor-Positive Metastatic Breast Cancer (A ComboMATCH Treatment Trial)
HR+ Metastatic Breast Cancer with NF1 nonsense or Frameshift Mutations or NF1 Gene Deletion This phase II ComboMATCH treatment trial…